![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dr. Martens Plc | LSE:DOCS | London | Ordinary Share | GB00BL6NGV24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.90 | 4.22% | 71.65 | 70.55 | 71.00 | 71.95 | 69.05 | 70.00 | 3,315,666 | 16:35:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Footwear-wholesale | 877.1M | 69.2M | 0.0719 | 25.31 | 661.36M |
Dr. Martens plc (the "Company")
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that on 14 June 2024 the following director / person discharging managerial responsibility ('PDMR') was granted a Performance Share Award (the "Award") under the Company's Long Term Incentive Plan (the 'LTIP').
PDMR |
Number of Shares |
Giles Wilson |
1,254,310 |
The Award was made to compensate Giles for loss of long-term incentive schemes forfeited on leaving his previous employer which he would otherwise have been eligible to receive. The measures, targets and weightings are aligned to the annual LTIP award also made and announced by the Company today, 14 June 2024, and will vest subject to the achievement of earnings per share (50% weighting), relative total shareholder return (25% weighting), and operating cash flow conversion (25% weighting) targets over three years and, on vesting, will be subject to a further two-year holding period.
No consideration was paid for the grant of the Award and no price is payable on the exercise of the Award.
Full details of the target ranges will be set out in the Directors' Remuneration Report contained within the 2025 Annual Report & Accounts.
The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Giles Wilson |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
PDMR (Chief Financial Officer) |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Dr. Martens plc |
||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||||
b) |
Nature of the transaction |
Grant of performance share award under the |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
|
||||||
e) |
Date of the transaction |
2024-06-14 |
||||||
f) |
Place of the transaction |
Outside a trading venue |
1 Year Dr. Martens Chart |
1 Month Dr. Martens Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions